Biome Medtech Private Limited
Healthcare services provider, incorporated in 2022, based in Bangalore.
2022 | Bangaluru, Karnataka (India) | Active
Biome Medtech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth %
- Profit Growth 1136.94%
- Ebitda -4495.09%
- Net Worth 66.19%
- Total Assets 317.91%
About Biome Medtech
Biome Medtech Private Limited (BMPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 March 2022 (Two years and 11 months 9 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 M.
Nikita Doshi and Bhavin Doshi serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33110KA2022PTC159070
- Company No.
159070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Healthcare
Who are the key members and board of directors at Biome Medtech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikita Doshi  | Director | 21-Mar-2022 | Current |
| Bhavin Doshi | Director | 21-Mar-2022 | Current |
Financial Performance of Biome Medtech.
Biome Medtech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1136.94% increase in profit. The company's net worth Soared by an impressive increase of 66.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biome Medtech?
In 2023, Biome Medtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biome Healthcare Private LimitedNikita Doshi and Bhavin Doshi are mutual person
Charges (Loans)
Open Charges
₹3.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2023 | Axis Bank Limited | ₹3.50 M | Open |
How Many Employees Work at Biome Medtech?
Biome Medtech has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biome Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biome Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.